Hang in there!!, page-159

More of a little curiosity or some funny pastime while we are waiting for official newsflow reg enrollment or partnering. But it seems as if AI is on our side! ;-)

„Medical trials are as expensive and time consuming as they are vital. But AI has emerged that might well be able to predict results.

Given that, a positive trial result can put a rocket up a biotech company’s share price, while a negative one can send it into a tailspin.

The wonders of artificial intelligence mean that it is possible to predict a trial result with 90 per cent accuracy, according to life-sciences nanocap Opyl.

Opthea (ASX:OPT) has two Phase 3 trials for the eye condition wet aged-related macular degeneration, due to report mid next year. Combining the company’s therapy with different “standard of care” drugs, the trials are rated a solid 63.8 per cent and 52.32 per cent chance of success.“

=> click here <=

To be taken with a grain of smile…